Journal blacklists doctor in Pakistan ‘out of an abundance of caution’

Following an investigation into possible paper mill activities, the journal Cureus has barred a doctor in Pakistan from publishing more papers “out of an abundance of caution,” Retraction Watch has learned.

The journal investigated Satish Kumar, an internist at Shaheed Mohtarma Benazir Bhutto Medical College in Karachi, after a tipster accused him of selling authorship of scientific papers to scientists who did not participate in the research. 

The tipster, who wishes to remain anonymous to avoid backlash from the authors of these papers, sent Cureus WhatsApp messages from a group called “research Match Residency.” There, a user named ”SSS” sent paper titles and offered author slots on manuscripts. Many of the articles were slated for publication in Cureus

Continue reading Journal blacklists doctor in Pakistan ‘out of an abundance of caution’

Paper claiming ‘extensive’ harms of COVID-19 vaccines to be retracted

A journal is retracting a paper on the purported harms of vaccines against COVID-19 written in part by authors who have had similar work retracted before.

The article, “COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign,” appeared late last month in Cureus, which used to be a stand-alone journal but is now owned by Springer Nature. (It has appeared frequently in these pages.)

Graham Parker, Director of Publishing and Customer Success at Cureus, told Retraction Watch:

I can confirm we will be retracting it by the end of the week, as we have provided the authors with a deadline to reply and indicate whether they agree or disagree with the retraction.

The senior author on the work was Peter McCullough, a cardiologist at the Institute of Pure and Applied Knowledge who lost his board certification after the American Board of Internal Medicine found he had “provided false or inaccurate medical information to the public.”

Continue reading Paper claiming ‘extensive’ harms of COVID-19 vaccines to be retracted

Journal retracts more than 50 studies from Saudi Arabia for faked authorship

The journal Cureus has retracted 56 papers nearly two years after it first began to suspect the works were of dubious lineage.

Cureus – an open access journal founded in 2009 and acquired by Springer Nature in 2022slapped 55 of the papers with expressions of concern in April 2022. At that time, at least one author said they didn’t know anything about the work and Cureus noted the “articles were submitted and subsequently published purportedly as an effort coordinated by Imam Abdulrahman Bin Faisal University to ensure all medical interns publish at least one peer-reviewed article in order to qualify for enrollment in a postgraduate residency program as stipulated by The Saudi Commission for Health Specialties (SCFHS).”

At the time, Cureus’ founding editor in chief John Adler told us “The investigation has been frustratingly slow due to the relative unresponsiveness of Saudi gov officials.” Apparently, that remained the case. This week, the journal retracted 56 studies. All of the retraction notices read the same way:

Continue reading Journal retracts more than 50 studies from Saudi Arabia for faked authorship

‘Nonsensical content’: Springer Nature journal breaks up with a paper on a love story

Majnun in the wilderness (credit)

You can love math, but can you math love? 

Scientific Reports has retracted a 2023 paper that tried to do just that by imposing a numerical model onto an ancient Persian love story that may have influenced Shakespeare’s Romeo and Juliet. 

The paper, “A fractional order nonlinear model of the love story of Layla and Majnun,” was written by Zulqurnain Sabir and Salem Ben Said, both mathematicians at United Arab Emirates University. The article has been cited three times, according to Clarivate Analytics’ Web of Science.

According to the abstract: 

Continue reading ‘Nonsensical content’: Springer Nature journal breaks up with a paper on a love story

Former Stanford president retracts Nature paper as another gets expression of concern

Marc Tessier-Lavigne

Marc Tessier-Lavigne, the former president of Stanford University who resigned earlier this year after an institutional research misconduct investigation, has retracted a paper from Nature. The journal’s editorial office marked another of Tessier-Lavigne’s articles with an expression of concern. 

The two Nature papers – which have together been cited more than 1,000 times, according to Clarivate’s Web of Science – were among five the university investigation examined on which Tessier-Lavigne was the principal author. The other three have been retracted – two from Science and one from Cell. In a statement posted to his lab website July 19, Tessier-Lavigne wrote that he planned to correct the two papers in Nature

The retracted article, “APP binds DR6 to trigger axon pruning and neuron death via distinct caspases,” appeared in 2009. It has been cited 816 times, according to Clarivate’s Web of Science. The retraction notice stated: 

Continue reading Former Stanford president retracts Nature paper as another gets expression of concern

PLOS backs down from expression of concern after author’s lawsuit

Soudamani Singh

A researcher who sued the publisher PLOS to prevent it from posting an expression of concern for one of her papers has dropped her suit, and the publisher tells us it will add a correction to the article instead – but may “revisit this case” to deal with “unresolved issues.”

We’ve previously reported on the lawsuit Soudamani Singh, an assistant professor in the Department of Clinical and Translational Sciences at Marshall University’s Joan C. Edwards School of Medicine in Huntington, W. Va., filed against PLOS in April, as well as signs of a pending settlement

According to an order filed November 2, Singh informed the court that she “voluntarily dismisses” the claims in her complaint, without the possibility of re-filing them, and the judge dismissed the case. 

In her complaint, Singh alleged that PLOS planned to place an expression of concern on one of her papers, “Cyclooxygenase pathway mediates the inhibition of Na-glutamine co-transporter B0AT1 in rabbit villus cells during chronic intestinal inflammation,” published in PLOS ONE in September 2018, after she and her co-authors had requested a correction of a duplicated image. The paper has been cited nine times, according to Clarivate’s Web of Science, but not since April 2021. 

Continue reading PLOS backs down from expression of concern after author’s lawsuit

Nature pulls study that found climate fears were overblown

It was that rarest of things: a sliver of good news about climate change.

According to calculations published last year in Nature, our planet was keeping pace, and then some, with rising emissions from tropical forest clearance by gobbling up more and more atmospheric carbon. 

“What we can mainly prove is that the worst nightmare scenarios of an impaired carbon sink have not yet materialised and that the news is not quite as bad,” Guido van der Werf, a professor at Vrije Universiteit Amsterdam, said in a press release at the time.

His coauthor Dave van Wees added:

Continue reading Nature pulls study that found climate fears were overblown

Frontiers retracts nearly 40 papers linked to ‘authorship-for-sale’

The publisher Frontiers has retracted nearly 40 papers across multiple journals linked to “the unethical practice of buying or selling authorship on research papers,” according to a press release posted to a company website Monday. 

The release also states Frontiers is adopting new policies to prevent the sale of authorships on papers it publishes. 

The publisher’s old policy simply stated that “Requests to modify the author list after submission should be made to the editorial office using the authorship change form.” 

Now, such requests “will only be granted under exceptional circumstances and after in-depth assessment by the Frontiers’ research integrity unit,” according to the release. The publisher will also keep track of the requests “to identify suspicious patterns and trends.”

Continue reading Frontiers retracts nearly 40 papers linked to ‘authorship-for-sale’

Stanford president retracts two Science papers following investigation

Marc Tessier-Lavigne

Marc Tessier-Lavigne, whose resignation as president of Stanford University becomes effective today, is retracting two papers from Science following an institutional investigation that found data manipulation in multiple figures. 

Both articles, “Hierarchical Organization of Guidance Receptors: Silencing of Netrin Attraction by Slit Through a Robo/DCC Receptor Complex,” and “Binding of DCC by Netrin-1 to Mediate Axon Guidance Independent of Adenosine A2B Receptor Activation,” were published in 2001, when Tessier-Lavigne, the corresponding author, was at the University of California, San Francisco. They have been cited well over 600 times in total, according to Clarivate’s Web of Science. 

Anonymous users on PubPeer posted concerns about potentially manipulated images in the papers as early as 2015. Reporting by The Stanford Daily in November 2022 spurred the university to launch an investigation into several of Tessier-Lavigne’s papers, how he responded when others identified issues in his articles, and the culture of his lab. 

The university published the final report last month, finding that four of the five papers it reviewed on which Tessier-Lavigne was a principal author contained “apparent manipulation of research data by others.” Tessier-Lavigne, the investigation committee concluded: 

Continue reading Stanford president retracts two Science papers following investigation

Nature editors retract influential cancer paper with “unreliable” data 

Janine Erler

Editors at Nature have retracted a 2015 paper on breast cancer metastases citing trouble with the data in the supplementary materials. 

The paper, “The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase,” was first published in May 2015 and has been cited 352 times, according to Clarivate’s Web of Science

This marks the second retraction for corresponding author Janine Erler, a professor in cancer biology at the University of Copenhagen. As previously reported by Retraction Watch, Nature in 2020 pulled a 2006 paper on which she was first author because of “image anomalies” and the absence of original data. Two other papers co-authored by Erler have been corrected and one additional paper has an expression of concern.

Continue reading Nature editors retract influential cancer paper with “unreliable” data